AUGUSTUS (Completed)
An open-label, 2 x 2 factorial, randomized controlled, clinical trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspririn vs. aspririn placebo in patients with atrial fibrillation and ACS or PCI
- Medicine
- apixaban
- Population
- ASCVD
- Phase
- IV
- Starting year
- 2015
- More information
- ClinicalTrials.gov